Takafumi Suzuki1, Kazutsugu Iwamoto2, Ryoichi Nozaki3, Yasumitsu Saiki4, Masafumi Tanaka4, Mitsuko Fukunaga4, Kazutaka Yamada4. 1. Department of Surgery, Coloproctology Center Takano Hospital, 3-2 Ooe, Kumamoto, Kumamoto, 862-0971, Japan. takafumi4966@gmail.com. 2. Department of Surgery, Shinkuki General Hospital, 418-1 Kamihayami, Kuki, Saitama, 346-8530, Japan. 3. Department of Gastroenterology, Coloproctology Center Takano Hospital, 3-2 Ooe, Kumamoto, Kumamoto, 862-0971, Japan. 4. Department of Surgery, Coloproctology Center Takano Hospital, 3-2 Ooe, Kumamoto, Kumamoto, 862-0971, Japan.
Abstract
BACKGROUND: Gastrointestinal lymphomas like diffuse large B-cell lymphoma (DLBCL) are rare complications of ulcerative colitis (UC), and only a few studies have reported intestinal ulcers caused by DLBCL, which got perforated during the treatment of UC. CASE PRESENTATION: A 43-year-old man with severe lower abdominal pain and an 8-year history of UC was admitted in our hospital. He was diagnosed UC since 8 years and received a maintenance oral dose of 5-aminosalicylic acid, and no other immunosuppressive drugs. A deep rectal ulcer was endoscopically diagnosed 10 months before admission, no malignancy or cytomegalovirus infection was detected on biopsy. After 7 months a further endoscopy with biopsies confirmed the finding and the absence of malignancy. Three months later the patient developed sudden abdominal pain and was admitted in our hospital. Rectal perforation was suspected on X-ray and computed tomography imaging, and an emergency surgery was performed. Surgical exploration revealed a perforation on the anterior wall of the rectum. A subtotal colectomy with temporary ileostomy was performed. Pathology examinations showed lymphocyte infiltration of all of the layers of the perforated site and an immunohistochemical evaluation revealed DLBCL. Clinical staging was stage IV, and the patient received a 6-months regimen of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) chemotherapy. Positron emission tomography restaging revealed disappearance of distant uptake and a slight uptake in the residual rectum, and completion proctectomy with ileal pouch-anal anastomosis was performed. No residual tumor in the specimen was found, and the patient was disease-free at 2 years follow-up. CONCLUSIONS: DLBCL may increase the frequency of perforation and is a poor prognostic risk factor for patients with UC. This case study emphasizes the importance of careful medical surveillance and repeated endoscopic biopsies during the treatment of UC.
BACKGROUND:Gastrointestinal lymphomas like diffuse large B-cell lymphoma (DLBCL) are rare complications of ulcerative colitis (UC), and only a few studies have reported intestinal ulcers caused by DLBCL, which got perforated during the treatment of UC. CASE PRESENTATION: A 43-year-old man with severe lower abdominal pain and an 8-year history of UC was admitted in our hospital. He was diagnosed UC since 8 years and received a maintenance oral dose of 5-aminosalicylic acid, and no other immunosuppressive drugs. A deep rectal ulcer was endoscopically diagnosed 10 months before admission, no malignancy or cytomegalovirus infection was detected on biopsy. After 7 months a further endoscopy with biopsies confirmed the finding and the absence of malignancy. Three months later the patient developed sudden abdominal pain and was admitted in our hospital. Rectal perforation was suspected on X-ray and computed tomography imaging, and an emergency surgery was performed. Surgical exploration revealed a perforation on the anterior wall of the rectum. A subtotal colectomy with temporary ileostomy was performed. Pathology examinations showed lymphocyte infiltration of all of the layers of the perforated site and an immunohistochemical evaluation revealed DLBCL. Clinical staging was stage IV, and the patient received a 6-months regimen of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) chemotherapy. Positron emission tomography restaging revealed disappearance of distant uptake and a slight uptake in the residual rectum, and completion proctectomy with ileal pouch-anal anastomosis was performed. No residual tumor in the specimen was found, and the patient was disease-free at 2 years follow-up. CONCLUSIONS: DLBCL may increase the frequency of perforation and is a poor prognostic risk factor for patients with UC. This case study emphasizes the importance of careful medical surveillance and repeated endoscopic biopsies during the treatment of UC.
Entities:
Keywords:
Diffuse large B-cell lymphoma; Intestinal perforation; Ulcerative colitis
Authors: Lisa J Herrinton; Liyan Liu; Xiaoping Weng; James D Lewis; Susan Hutfless; James E Allison Journal: Am J Gastroenterol Date: 2011-10-25 Impact factor: 10.864
Authors: Florian Beigel; Anni Steinborn; Fabian Schnitzler; Cornelia Tillack; Simone Breiteneicher; Jestinah Mahachie John; Kristel Van Steen; Rüdiger P Laubender; Burkhard Göke; Julia Seiderer; Stephan Brand; Thomas Ochsenkühn Journal: Pharmacoepidemiol Drug Saf Date: 2014-04-30 Impact factor: 2.890
Authors: A Rohatiner; F d'Amore; B Coiffier; D Crowther; M Gospodarowicz; P Isaacson; T A Lister; A Norton; P Salem; M Shipp Journal: Ann Oncol Date: 1994-05 Impact factor: 32.976